BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  10x Genomics Enables High-Volume Studies By Providing More Affordable Solutions For Whole Genome And Exome Analysis

  10x Genomics announced more affordable pricing for their Chromium Genome, Exome and de novo Assembly Solutions.

  October 18, 2017

   · 

  5 min read
• Drug Development

  Synspira Announces First Patient Dosed In Phase 1a Study Of SNSP113 In Cystic Fibrosis

  Synspir announced initiation of a Phase 1a first-in-human, multi-center study of SNSP113, its lead drug candidate, in development for use in pulmonary complications of cystic fibrosis (CF).

  October 18, 2017

   · 

  4 min read
• Bio NC

  PPD Hero Leads Team Supporting Multiple Sclerosis Research

  Pharmaceutical Product Development is sponsoring Walk MS: Austin as part of the PPD Heroes initiative to raise awareness about the life-changing impact of clinical research for patients.

  October 18, 2017

   · 

  3 min read
• Business

  AbbVie and Harpoon Therapeutics Announce Immuno-Oncology Research Collaboration

  AbbVie and Harpoon Therapeutics announced today that they have entered an immuno-oncology research collaboration.

  October 18, 2017

   · 

  3 min read
• Drug Development

  AMO Pharma Presents Positive Interim Analysis of Data from Congenital Myotonic Dystrophy Study at American Neurological Association Annual Meeting

  AMO Pharma presented positive interim analysis of data from the first cohort of its study of AMO-02 in congenital myotonic dystrophy.

  October 18, 2017

   · 

  3 min read
• Drug Development

  BioLineRx Announces Initiation of Phase Ib/2 Trial for BL-80040 in Gastric Cancer Under Immunotherapy Collaboration

  BioLineRx announced today that Genentech has commenced a Phase 1b/2 study for the treatment of gastric cancer with BL-8040 in combination with atezolizumab, Genentech’s anti-PDL1 cancer immunotherapy agent.

  October 18, 2017

   · 

  6 min read
• Drug Development

  Merck’s KEYTRUDA (Pembrolizumab) More Than Doubled Median Overall Survival Compared To Chemotherapy After Two Years Of Follow Up In First-Line Treatment Of Patients With Metastatic Non-Small Cell Lung Cancer With High Levels Of PD-L1

  Merck announced the presentation of updated overall survival (OS) findings, a secondary endpoint, from the phase 3 KEYNOTE-024 trial evaluating KEYTRUDA (pembrolizumab).

  October 18, 2017

   · 

  27 min read
• Business

  Ionis Enters into Collaboration With Seventh Sense Biosystems to Support Development of Improved Blood Collection and Diagnostic Device

  As part of its commitment to the collaboration, Ionis has made a strategic investment of $2 million in 7SBio.

  October 18, 2017

   · 

  4 min read
• 

  FDA

  FDA Green Lights OptiScan’s Glucose Monitoring System for the ICU

  The OptiScanner 5000 is the first-of-its-kind automated bedside glucose monitoring system that provides physicians information to manage patient glucose levels in the ICU.

  October 18, 2017

   · 

  4 min read
• Medicenna Announces Trading on the OTCQX Best Market in the United States

  Medicenna is pleased to announce that the Company has received approval to commence trading on the OTCQX Best Market, under the symbol, “MDNAF”.

  October 18, 2017

   · 

  4 min read